This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Retropubic mid-urethral mesh sling for stress urinary incontinence

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Mid-urethral mesh sling procedure

  • when considering this procedure then advise the woman that it is a permanent implant and complete removal might not be possible

  • if a retropubic mid-urethral mesh sling is inserted, then the woman should be given written information about the implant, including its name, manufacturer, date of insertion, and the implanting surgeon's name and contact details
    • for the procedure
      • use a device manufactured from type 1 macroporous polypropylene mesh
      • consider using a retropubic mid-urethral mesh sling coloured for high visibility, for ease of insertion and revision

      • the procedure involves involves the passage of a small strip of tape through the retropubic space, with entry or exit points at the lower abdomen
  • transobturator approach should not be used unless there are specific clinical circumstances (for example, previous pelvic procedures) in which the retropubic approach should be avoided
  • 'top-down' retropubic mid-urethral mesh sling approach or single-incision sub-urethral short mesh sling insertion should not be used except as part of a clinical trial

For detailed information then consult NICE guideline (1).


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.